UK SAYS IT IS TOO EARLY TO KNOW WHETHER OMICRON VARIANT HAS ANY IMPACT ON SOTROVIMAB'S EFFECTIVENESS BUT MHRA WILL WORK WITH COMPANY TO ESTABLISH THIS